التجارب السريرية بالأسفل التجارب السريرية الحالية.76 دراسات في الأشعة (افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. Potential Benefit of Photon-counting CT in Human Subjects Rochester, Minn. The purpose of this study is to to examine the ability of photon counting computed tomography (PCCT) to reduce calcium blooming and beam-hardening artifacts adjacent to bone, to use decreased dose levels without altering contrast-to-noise, and to improve discrimination of very small structures using the system’s increased spatial resolution. A Study to Assess Opioid-Induced Respiratory Depression Using Diaphragm Muscle Shear Wave Elastography Rochester, Minn. The purpose of this study is to determine the impact of opioid administration on diaphragm muscle forces during resting breathing and during higher force maneuvers by using a non-invasive shear wave elastography (SWE) method. Detection of Vascular and Inflammatory Plasma Biomarkers in Patients Diagnosed with Obstructive Sleep Apnea and MRI-defined Cerebral Small Vessel Disease Jacksonville, Fla. The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea (OSA) and pre-existing imaging evidence of Cerebral Small Vessel Disease (CSVD). 3D Ultrasound Imaging for Breast Cancer Diagnosis Rochester, Minn. The purpose of this study is to evaluate the effectiveess of a new 3D ultrasound imaging technology combining B-mode, microvessel imaging, shear wave elastography, and machine learning for breast lesion diagnosis. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The overall objective of this project is to combine robust clinical data (e.g. prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in radiotheranostic treated solid tumor patients. Image-based Mapping of Brain Tumors Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment. A Study to Evaluate Evacuation Mechanisms Using Advanced Brain Imaging Rochester, Minn. The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without DD, and 30 constipated patients with DD at rest (functional connectivity analysis), during rectal distention to desire to defecate and urgency, and during evacuation. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography Rochester, Minn. The purpose of this research study is testing a new technique for measuring stiffness of the lung. This new technique is called Magnetic Resonance Elastography (MRE). In this study we will look at the stiffness measurements in humans. Actinium Therapy For Late-stage Aggressive Sarcomas Rochester, Minn. The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio Therapeutics will learn if \[Ac225\]RTX-2358 drug is effective in treating advanced sarcoma.The main questions the study aims to answer in Phase/Part 1 of the trial are:* Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in patients.* What is the most tolerable dose of \[Ac225\]RTX-2358* Does the treatment show effectiveness on advanced sarcomaParticipants will:* Take drug \[Ac225\]RTX-2358 once every 8 weeks (4 cycle target; 6 cycle maximum) over a period of 12 months* Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 for check-ups and tests.* For cycles 2-6: patient will visit the clinic once every 2 weeks for checkups and tests* Remain in long term follow-up for a period of four additional years A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline Rochester, Minn., Jacksonville, Fla. Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB التصفّح دراسات سريرية السابقالصفحة السابقة توجّه للصفحة 33 توجّه للصفحة 44 توجّه للصفحة 55 توجّه للصفحة 66 توجّه للصفحة 77 التاليالصفحة التالية بالأسفل التجارب السريرية الحالية.76 دراسات في الأشعة (افتح الدراسات فقط). غربل قائمة الدراسات هذه بالموقع والحالة وغيرها. Potential Benefit of Photon-counting CT in Human Subjects Rochester, Minn. The purpose of this study is to to examine the ability of photon counting computed tomography (PCCT) to reduce calcium blooming and beam-hardening artifacts adjacent to bone, to use decreased dose levels without altering contrast-to-noise, and to improve discrimination of very small structures using the system’s increased spatial resolution. A Study to Assess Opioid-Induced Respiratory Depression Using Diaphragm Muscle Shear Wave Elastography Rochester, Minn. The purpose of this study is to determine the impact of opioid administration on diaphragm muscle forces during resting breathing and during higher force maneuvers by using a non-invasive shear wave elastography (SWE) method. Detection of Vascular and Inflammatory Plasma Biomarkers in Patients Diagnosed with Obstructive Sleep Apnea and MRI-defined Cerebral Small Vessel Disease Jacksonville, Fla. The purpose of this study is to evaluate plasma biomarkers of vascular function and inflammation in patients with newly-diagnosed Obstructive Sleep Apnea (OSA) and pre-existing imaging evidence of Cerebral Small Vessel Disease (CSVD). 3D Ultrasound Imaging for Breast Cancer Diagnosis Rochester, Minn. The purpose of this study is to evaluate the effectiveess of a new 3D ultrasound imaging technology combining B-mode, microvessel imaging, shear wave elastography, and machine learning for breast lesion diagnosis. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The overall objective of this project is to combine robust clinical data (e.g. prior chemotherapy or radiation exposure, cumulative radiotheranostic dose) with geneticclonal abnormalities (blood-based CHIP panel) in studying the predisposing risk factors for developing hematological toxicity including t-MN in radiotheranostic treated solid tumor patients. Image-based Mapping of Brain Tumors Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and tissue samples) to improve the overall accuracy of diagnosis and effectiveness of cancer treatment. A Study to Evaluate Evacuation Mechanisms Using Advanced Brain Imaging Rochester, Minn. The objective of this study is to compare the central neural circuitry with fMRI (7T) in 30 asymptomatic healthy controls, 30 constipated patients without DD, and 30 constipated patients with DD at rest (functional connectivity analysis), during rectal distention to desire to defecate and urgency, and during evacuation. Assessment of the Mechanical Properties of Lung Parenchyma using Magnetic Resonance Elastography Rochester, Minn. The purpose of this research study is testing a new technique for measuring stiffness of the lung. This new technique is called Magnetic Resonance Elastography (MRE). In this study we will look at the stiffness measurements in humans. Actinium Therapy For Late-stage Aggressive Sarcomas Rochester, Minn. The goal of this clinical trial is to learn about the safety of drug \[Ac225\]RTX-2358 and the diagnostic imaging agent \[Cu64\]LNTH-1363S. Additionally Ratio Therapeutics will learn if \[Ac225\]RTX-2358 drug is effective in treating advanced sarcoma.The main questions the study aims to answer in Phase/Part 1 of the trial are:* Is \[Ac225\]RTX-2358 tolerable or does it cause toxicities (medical problems) in patients.* What is the most tolerable dose of \[Ac225\]RTX-2358* Does the treatment show effectiveness on advanced sarcomaParticipants will:* Take drug \[Ac225\]RTX-2358 once every 8 weeks (4 cycle target; 6 cycle maximum) over a period of 12 months* Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 weeks of cycle 1 for check-ups and tests.* For cycles 2-6: patient will visit the clinic once every 2 weeks for checkups and tests* Remain in long term follow-up for a period of four additional years A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline Rochester, Minn., Jacksonville, Fla. Longitudinal Imaging Biomarkers of Disease Progression in Prodromal and Overt DLB التصفّح دراسات سريرية السابقالصفحة السابقة توجّه للصفحة 33 توجّه للصفحة 44 توجّه للصفحة 55 توجّه للصفحة 66 توجّه للصفحة 77 التاليالصفحة التالية طلب تحديد موعد الخبرة و مراتب التصنيفالأبحاث 14/02/2026 تبادلها عبر ارسلها على الفيس بوكارسلها في تغريدة الأشعةالأجزاءنظرة عامةالاختبارات والتشخيصالحلات التي يتم علاجهاالأطباءالأطباء حسب الموقع والتخصُّصمجموعات التخصصالخبرة و مراتب التصنيفالتجارب السريريةالأبحاثالتكاليف والتأمين الصحيالأخبار من Mayo Clinicإحالةالمرضى الأبحاث: المرضى محور اهتمامنا إظهار النسخة النصية للفيديو الأبحاث: المرضى محور اهتمامنا [عزف موسيقي] جوزيف سيرفين، دكتور في الطب، أستاذ طب الأعصاب في مايو كلينك: تتمثّل مهمة مايو في رعاية المريض. فمصلحة المريض أولًا. ولذلك فإن مهمّتنا وأبحاثنا تهدف إلى إحراز التقدّم في طريقة الاعتناء بالمريض، وتقديم مصلحته على كل الجوانب الأخرى من الرعاية. وهذا من عدة أوجه أقرب إلى دورة متعاقبة المراحل. فالأمر يبدأ بفكرة بسيطة ثبت نجاحها في المختبر، ثم طُبِّقت على المريض في سريره، وإذا سار كل شيء على ما يرام -بمعنى أنها كانت مفيدة له- فإننا نعتمدها على أنها نهج قياسي. وهذا في رأيي واحد من السمات الفريدة التي تميّز نهج مايو كلينك في البحث -أعني التركيز على المريض- وهو يساعد بحق في تمييزه عمّا سواه. الأجزاءطلب موعدنظرة عامةالاختبارات والتشخيصالحلات التي يتم علاجهاالأطباءالأطباء حسب الموقع والتخصُّصمجموعات التخصصالخبرة و مراتب التصنيفالتجارب السريريةالأبحاثالتكاليف والتأمين الصحيالأخبار من Mayo Clinicإحالة المرضى ORG-20469617 الأقسام والمراكز الطبية الأشعة